nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Goserelin—Immune system disorder—Prednisone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Goserelin—Malaise—Betamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Goserelin—Malaise—Dexamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Goserelin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Goserelin—Oedema—Triamcinolone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Goserelin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Goserelin—Arrhythmia—Prednisone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Goserelin—Infection—Triamcinolone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Goserelin—Sweating—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Goserelin—Infection—Methylprednisolone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Goserelin—Haematuria—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Goserelin—Shock—Triamcinolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Goserelin—Insomnia—Prednisolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Goserelin—Alopecia—Prednisone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Goserelin—Shock—Methylprednisolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Goserelin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Goserelin—Epistaxis—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Goserelin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Goserelin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Goserelin—Mental disorder—Prednisone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Goserelin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Goserelin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Goserelin—Malnutrition—Prednisone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Goserelin—Erythema—Prednisone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Goserelin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Goserelin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Goserelin—Convulsion—Betamethasone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Goserelin—Convulsion—Dexamethasone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Goserelin—Hypertension—Dexamethasone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Goserelin—Hypertension—Betamethasone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Goserelin—Myalgia—Betamethasone—ankylosing spondylitis	0.000995	0.000995	CcSEcCtD
Goserelin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000995	0.000995	CcSEcCtD
Goserelin—Anxiety—Betamethasone—ankylosing spondylitis	0.000991	0.000991	CcSEcCtD
Goserelin—Anxiety—Dexamethasone—ankylosing spondylitis	0.000991	0.000991	CcSEcCtD
Goserelin—Discomfort—Betamethasone—ankylosing spondylitis	0.000983	0.000983	CcSEcCtD
Goserelin—Discomfort—Dexamethasone—ankylosing spondylitis	0.000983	0.000983	CcSEcCtD
Goserelin—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000982	0.000982	CcSEcCtD
Goserelin—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00098	0.00098	CcSEcCtD
Goserelin—Pain—Prednisolone—ankylosing spondylitis	0.000977	0.000977	CcSEcCtD
Goserelin—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000977	0.000977	CcSEcCtD
Goserelin—Hepatitis—Methotrexate—ankylosing spondylitis	0.000977	0.000977	CcSEcCtD
Goserelin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000969	0.000969	CcSEcCtD
Goserelin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000965	0.000965	CcSEcCtD
Goserelin—Vision blurred—Prednisone—ankylosing spondylitis	0.000959	0.000959	CcSEcCtD
Goserelin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000957	0.000957	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000957	0.000957	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000955	0.000955	CcSEcCtD
Goserelin—Oedema—Dexamethasone—ankylosing spondylitis	0.000953	0.000953	CcSEcCtD
Goserelin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000953	0.000953	CcSEcCtD
Goserelin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000953	0.000953	CcSEcCtD
Goserelin—Oedema—Betamethasone—ankylosing spondylitis	0.000953	0.000953	CcSEcCtD
Goserelin—Insomnia—Triamcinolone—ankylosing spondylitis	0.00095	0.00095	CcSEcCtD
Goserelin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000948	0.000948	CcSEcCtD
Goserelin—Infection—Betamethasone—ankylosing spondylitis	0.000947	0.000947	CcSEcCtD
Goserelin—Infection—Dexamethasone—ankylosing spondylitis	0.000947	0.000947	CcSEcCtD
Goserelin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000944	0.000944	CcSEcCtD
Goserelin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000943	0.000943	CcSEcCtD
Goserelin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000942	0.000942	CcSEcCtD
Goserelin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000941	0.000941	CcSEcCtD
Goserelin—Anaemia—Prednisone—ankylosing spondylitis	0.00094	0.00094	CcSEcCtD
Goserelin—Shock—Betamethasone—ankylosing spondylitis	0.000938	0.000938	CcSEcCtD
Goserelin—Shock—Dexamethasone—ankylosing spondylitis	0.000938	0.000938	CcSEcCtD
Goserelin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000937	0.000937	CcSEcCtD
Goserelin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000935	0.000935	CcSEcCtD
Goserelin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000935	0.000935	CcSEcCtD
Goserelin—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000933	0.000933	CcSEcCtD
Goserelin—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000933	0.000933	CcSEcCtD
Goserelin—Tachycardia—Betamethasone—ankylosing spondylitis	0.00093	0.00093	CcSEcCtD
Goserelin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00093	0.00093	CcSEcCtD
Goserelin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000925	0.000925	CcSEcCtD
Goserelin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000923	0.000923	CcSEcCtD
Goserelin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000922	0.000922	CcSEcCtD
Goserelin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000922	0.000922	CcSEcCtD
Goserelin—Malaise—Prednisone—ankylosing spondylitis	0.000917	0.000917	CcSEcCtD
Goserelin—Eye disorder—Methotrexate—ankylosing spondylitis	0.000913	0.000913	CcSEcCtD
Goserelin—Anorexia—Dexamethasone—ankylosing spondylitis	0.000909	0.000909	CcSEcCtD
Goserelin—Anorexia—Betamethasone—ankylosing spondylitis	0.000909	0.000909	CcSEcCtD
Goserelin—Urticaria—Prednisolone—ankylosing spondylitis	0.000908	0.000908	CcSEcCtD
Goserelin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000906	0.000906	CcSEcCtD
Goserelin—Fatigue—Triamcinolone—ankylosing spondylitis	0.000906	0.000906	CcSEcCtD
Goserelin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000904	0.000904	CcSEcCtD
Goserelin—Pain—Triamcinolone—ankylosing spondylitis	0.000899	0.000899	CcSEcCtD
Goserelin—Hypotension—Dexamethasone—ankylosing spondylitis	0.000891	0.000891	CcSEcCtD
Goserelin—Hypotension—Betamethasone—ankylosing spondylitis	0.000891	0.000891	CcSEcCtD
Goserelin—Angiopathy—Methotrexate—ankylosing spondylitis	0.000886	0.000886	CcSEcCtD
Goserelin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000882	0.000882	CcSEcCtD
Goserelin—Convulsion—Prednisone—ankylosing spondylitis	0.000881	0.000881	CcSEcCtD
Goserelin—Hypertension—Prednisone—ankylosing spondylitis	0.000878	0.000878	CcSEcCtD
Goserelin—Chills—Methotrexate—ankylosing spondylitis	0.000876	0.000876	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000869	0.000869	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000869	0.000869	CcSEcCtD
Goserelin—Myalgia—Prednisone—ankylosing spondylitis	0.000866	0.000866	CcSEcCtD
Goserelin—Arthralgia—Prednisone—ankylosing spondylitis	0.000866	0.000866	CcSEcCtD
Goserelin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000866	0.000866	CcSEcCtD
Goserelin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000864	0.000864	CcSEcCtD
Goserelin—Anxiety—Prednisone—ankylosing spondylitis	0.000863	0.000863	CcSEcCtD
Goserelin—Alopecia—Methotrexate—ankylosing spondylitis	0.000863	0.000863	CcSEcCtD
Goserelin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000862	0.000862	CcSEcCtD
Goserelin—Insomnia—Betamethasone—ankylosing spondylitis	0.000862	0.000862	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00086	0.00086	CcSEcCtD
Goserelin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000857	0.000857	CcSEcCtD
Goserelin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000856	0.000856	CcSEcCtD
Goserelin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000856	0.000856	CcSEcCtD
Goserelin—Discomfort—Prednisone—ankylosing spondylitis	0.000856	0.000856	CcSEcCtD
Goserelin—Mental disorder—Methotrexate—ankylosing spondylitis	0.000856	0.000856	CcSEcCtD
Goserelin—Erythema—Methotrexate—ankylosing spondylitis	0.00085	0.00085	CcSEcCtD
Goserelin—Malnutrition—Methotrexate—ankylosing spondylitis	0.00085	0.00085	CcSEcCtD
Goserelin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000842	0.000842	CcSEcCtD
Goserelin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000839	0.000839	CcSEcCtD
Goserelin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000839	0.000839	CcSEcCtD
Goserelin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000835	0.000835	CcSEcCtD
Goserelin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000833	0.000833	CcSEcCtD
Goserelin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000831	0.000831	CcSEcCtD
Goserelin—Oedema—Prednisone—ankylosing spondylitis	0.00083	0.00083	CcSEcCtD
Goserelin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00083	0.00083	CcSEcCtD
Goserelin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000829	0.000829	CcSEcCtD
Goserelin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000829	0.000829	CcSEcCtD
Goserelin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000829	0.000829	CcSEcCtD
Goserelin—Infection—Prednisone—ankylosing spondylitis	0.000825	0.000825	CcSEcCtD
Goserelin—Back pain—Methotrexate—ankylosing spondylitis	0.000822	0.000822	CcSEcCtD
Goserelin—Fatigue—Betamethasone—ankylosing spondylitis	0.000822	0.000822	CcSEcCtD
Goserelin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000822	0.000822	CcSEcCtD
Goserelin—Shock—Prednisone—ankylosing spondylitis	0.000817	0.000817	CcSEcCtD
Goserelin—Pain—Dexamethasone—ankylosing spondylitis	0.000815	0.000815	CcSEcCtD
Goserelin—Pain—Betamethasone—ankylosing spondylitis	0.000815	0.000815	CcSEcCtD
Goserelin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000814	0.000814	CcSEcCtD
Goserelin—Tachycardia—Prednisone—ankylosing spondylitis	0.00081	0.00081	CcSEcCtD
Goserelin—Skin disorder—Prednisone—ankylosing spondylitis	0.000806	0.000806	CcSEcCtD
Goserelin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000803	0.000803	CcSEcCtD
Goserelin—Vision blurred—Methotrexate—ankylosing spondylitis	0.000801	0.000801	CcSEcCtD
Goserelin—Anorexia—Prednisone—ankylosing spondylitis	0.000791	0.000791	CcSEcCtD
Goserelin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000789	0.000789	CcSEcCtD
Goserelin—Anaemia—Methotrexate—ankylosing spondylitis	0.000786	0.000786	CcSEcCtD
Goserelin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000786	0.000786	CcSEcCtD
Goserelin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000786	0.000786	CcSEcCtD
Goserelin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00078	0.00078	CcSEcCtD
Goserelin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00078	0.00078	CcSEcCtD
Goserelin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000774	0.000774	CcSEcCtD
Goserelin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000772	0.000772	CcSEcCtD
Goserelin—Malaise—Methotrexate—ankylosing spondylitis	0.000767	0.000767	CcSEcCtD
Goserelin—Leukopenia—Methotrexate—ankylosing spondylitis	0.000761	0.000761	CcSEcCtD
Goserelin—Urticaria—Betamethasone—ankylosing spondylitis	0.000757	0.000757	CcSEcCtD
Goserelin—Urticaria—Dexamethasone—ankylosing spondylitis	0.000757	0.000757	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000756	0.000756	CcSEcCtD
Goserelin—Dizziness—Prednisolone—ankylosing spondylitis	0.000756	0.000756	CcSEcCtD
Goserelin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000754	0.000754	CcSEcCtD
Goserelin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000754	0.000754	CcSEcCtD
Goserelin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000754	0.000754	CcSEcCtD
Goserelin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000754	0.000754	CcSEcCtD
Goserelin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000754	0.000754	CcSEcCtD
Goserelin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000752	0.000752	CcSEcCtD
Goserelin—Insomnia—Prednisone—ankylosing spondylitis	0.000751	0.000751	CcSEcCtD
Goserelin—Paraesthesia—Prednisone—ankylosing spondylitis	0.000746	0.000746	CcSEcCtD
Goserelin—Pruritus—Triamcinolone—ankylosing spondylitis	0.000743	0.000743	CcSEcCtD
Goserelin—Cough—Methotrexate—ankylosing spondylitis	0.000742	0.000742	CcSEcCtD
Goserelin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000742	0.000742	CcSEcCtD
Goserelin—Convulsion—Methotrexate—ankylosing spondylitis	0.000737	0.000737	CcSEcCtD
Goserelin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000731	0.000731	CcSEcCtD
Goserelin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000724	0.000724	CcSEcCtD
Goserelin—Chest pain—Methotrexate—ankylosing spondylitis	0.000724	0.000724	CcSEcCtD
Goserelin—Myalgia—Methotrexate—ankylosing spondylitis	0.000724	0.000724	CcSEcCtD
Goserelin—Decreased appetite—Prednisone—ankylosing spondylitis	0.000722	0.000722	CcSEcCtD
Goserelin—Rash—Prednisolone—ankylosing spondylitis	0.00072	0.00072	CcSEcCtD
Goserelin—Dermatitis—Prednisolone—ankylosing spondylitis	0.00072	0.00072	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000719	0.000719	CcSEcCtD
Goserelin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000717	0.000717	CcSEcCtD
Goserelin—Fatigue—Prednisone—ankylosing spondylitis	0.000716	0.000716	CcSEcCtD
Goserelin—Headache—Prednisolone—ankylosing spondylitis	0.000716	0.000716	CcSEcCtD
Goserelin—Discomfort—Methotrexate—ankylosing spondylitis	0.000715	0.000715	CcSEcCtD
Goserelin—Constipation—Prednisone—ankylosing spondylitis	0.00071	0.00071	CcSEcCtD
Goserelin—Confusional state—Methotrexate—ankylosing spondylitis	0.0007	0.0007	CcSEcCtD
Goserelin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000695	0.000695	CcSEcCtD
Goserelin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000694	0.000694	CcSEcCtD
Goserelin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000693	0.000693	CcSEcCtD
Goserelin—Infection—Methotrexate—ankylosing spondylitis	0.000689	0.000689	CcSEcCtD
Goserelin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000684	0.000684	CcSEcCtD
Goserelin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000684	0.000684	CcSEcCtD
Goserelin—Asthenia—Betamethasone—ankylosing spondylitis	0.000684	0.000684	CcSEcCtD
Goserelin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00068	0.00068	CcSEcCtD
Goserelin—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000679	0.000679	CcSEcCtD
Goserelin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000679	0.000679	CcSEcCtD
Goserelin—Nausea—Prednisolone—ankylosing spondylitis	0.000679	0.000679	CcSEcCtD
Goserelin—Pruritus—Dexamethasone—ankylosing spondylitis	0.000675	0.000675	CcSEcCtD
Goserelin—Pruritus—Betamethasone—ankylosing spondylitis	0.000675	0.000675	CcSEcCtD
Goserelin—Skin disorder—Methotrexate—ankylosing spondylitis	0.000674	0.000674	CcSEcCtD
Goserelin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000671	0.000671	CcSEcCtD
Goserelin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000668	0.000668	CcSEcCtD
Goserelin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000667	0.000667	CcSEcCtD
Goserelin—Rash—Triamcinolone—ankylosing spondylitis	0.000663	0.000663	CcSEcCtD
Goserelin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000662	0.000662	CcSEcCtD
Goserelin—Anorexia—Methotrexate—ankylosing spondylitis	0.000661	0.000661	CcSEcCtD
Goserelin—Rash—Methylprednisolone—ankylosing spondylitis	0.000661	0.000661	CcSEcCtD
Goserelin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00066	0.00066	CcSEcCtD
Goserelin—Urticaria—Prednisone—ankylosing spondylitis	0.00066	0.00066	CcSEcCtD
Goserelin—Headache—Triamcinolone—ankylosing spondylitis	0.000658	0.000658	CcSEcCtD
Goserelin—Headache—Methylprednisolone—ankylosing spondylitis	0.000657	0.000657	CcSEcCtD
Goserelin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000656	0.000656	CcSEcCtD
Goserelin—Body temperature increased—Prednisone—ankylosing spondylitis	0.000656	0.000656	CcSEcCtD
Goserelin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000652	0.000652	CcSEcCtD
Goserelin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000652	0.000652	CcSEcCtD
Goserelin—Hypotension—Methotrexate—ankylosing spondylitis	0.000648	0.000648	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000632	0.000632	CcSEcCtD
Goserelin—Dizziness—Betamethasone—ankylosing spondylitis	0.00063	0.00063	CcSEcCtD
Goserelin—Dizziness—Dexamethasone—ankylosing spondylitis	0.00063	0.00063	CcSEcCtD
Goserelin—Insomnia—Methotrexate—ankylosing spondylitis	0.000628	0.000628	CcSEcCtD
Goserelin—Nausea—Triamcinolone—ankylosing spondylitis	0.000624	0.000624	CcSEcCtD
Goserelin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000623	0.000623	CcSEcCtD
Goserelin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000623	0.000623	CcSEcCtD
Goserelin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000619	0.000619	CcSEcCtD
Goserelin—Somnolence—Methotrexate—ankylosing spondylitis	0.000617	0.000617	CcSEcCtD
Goserelin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000612	0.000612	CcSEcCtD
Goserelin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000611	0.000611	CcSEcCtD
Goserelin—Vomiting—Betamethasone—ankylosing spondylitis	0.000606	0.000606	CcSEcCtD
Goserelin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000606	0.000606	CcSEcCtD
Goserelin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000603	0.000603	CcSEcCtD
Goserelin—Rash—Betamethasone—ankylosing spondylitis	0.000601	0.000601	CcSEcCtD
Goserelin—Rash—Dexamethasone—ankylosing spondylitis	0.000601	0.000601	CcSEcCtD
Goserelin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000601	0.000601	CcSEcCtD
Goserelin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000601	0.000601	CcSEcCtD
Goserelin—Fatigue—Methotrexate—ankylosing spondylitis	0.000598	0.000598	CcSEcCtD
Goserelin—Headache—Dexamethasone—ankylosing spondylitis	0.000597	0.000597	CcSEcCtD
Goserelin—Headache—Betamethasone—ankylosing spondylitis	0.000597	0.000597	CcSEcCtD
Goserelin—Asthenia—Prednisone—ankylosing spondylitis	0.000596	0.000596	CcSEcCtD
Goserelin—Pain—Methotrexate—ankylosing spondylitis	0.000593	0.000593	CcSEcCtD
Goserelin—Pruritus—Prednisone—ankylosing spondylitis	0.000587	0.000587	CcSEcCtD
Goserelin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000572	0.000572	CcSEcCtD
Goserelin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000568	0.000568	CcSEcCtD
Goserelin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000567	0.000567	CcSEcCtD
Goserelin—Nausea—Betamethasone—ankylosing spondylitis	0.000566	0.000566	CcSEcCtD
Goserelin—Nausea—Dexamethasone—ankylosing spondylitis	0.000566	0.000566	CcSEcCtD
Goserelin—Urticaria—Methotrexate—ankylosing spondylitis	0.000551	0.000551	CcSEcCtD
Goserelin—Dizziness—Prednisone—ankylosing spondylitis	0.000549	0.000549	CcSEcCtD
Goserelin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000549	0.000549	CcSEcCtD
Goserelin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000549	0.000549	CcSEcCtD
Goserelin—Vomiting—Prednisone—ankylosing spondylitis	0.000528	0.000528	CcSEcCtD
Goserelin—Rash—Prednisone—ankylosing spondylitis	0.000524	0.000524	CcSEcCtD
Goserelin—Dermatitis—Prednisone—ankylosing spondylitis	0.000523	0.000523	CcSEcCtD
Goserelin—Headache—Prednisone—ankylosing spondylitis	0.00052	0.00052	CcSEcCtD
Goserelin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000511	0.000511	CcSEcCtD
Goserelin—Asthenia—Methotrexate—ankylosing spondylitis	0.000498	0.000498	CcSEcCtD
Goserelin—Nausea—Prednisone—ankylosing spondylitis	0.000493	0.000493	CcSEcCtD
Goserelin—Pruritus—Methotrexate—ankylosing spondylitis	0.000491	0.000491	CcSEcCtD
Goserelin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000475	0.000475	CcSEcCtD
Goserelin—Dizziness—Methotrexate—ankylosing spondylitis	0.000459	0.000459	CcSEcCtD
Goserelin—Vomiting—Methotrexate—ankylosing spondylitis	0.000441	0.000441	CcSEcCtD
Goserelin—Rash—Methotrexate—ankylosing spondylitis	0.000438	0.000438	CcSEcCtD
Goserelin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000437	0.000437	CcSEcCtD
Goserelin—Headache—Methotrexate—ankylosing spondylitis	0.000435	0.000435	CcSEcCtD
Goserelin—Nausea—Methotrexate—ankylosing spondylitis	0.000412	0.000412	CcSEcCtD
